tirzepatide lean mass loss Prevent muscle to lower GLP-1 and GIP spend A drug called apitegromab may

Exceeding these doses is not recommended, as safety and efficacy data beyond these levels are limited

Jensen EP, Poulsen SS, Kissow H, Holstein-Rathlou NH, Deacon CF, Jensen BL, et al

Triple-Hormone-Receptor Agonist Retatrutide for Obesity A Phase 2 Trial. The New England Journal of Medicine

Upon initiation of a GLP-1 RAs and during up-titration, it is advisable for cardiologists to counsel their patients to take smaller meals, eat slowly and stop before feeling full, and avoid fatty or spicy foods ( 4 Conclusion GLP-1 RAs seem to emulate the evolution of statins and sodium-glucose co-transporter-2 inhibitors in terms of being approved for indications other than their initial indication and becoming promising agents in CV medicine which will continue to grow